Caitong International Asset Management Co., LTD Ligand Pharmaceuticals Inc Transaction History
Caitong International Asset Management Co., LTD
- $134 Billion
- Q1 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 3 shares of LGND stock, worth $342. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3
Previous 90
96.67%
Holding current value
$342
Previous $9.64 Million
96.73%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding LGND
# of Institutions
280Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$328 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$235 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$117 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$103 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$85 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.93B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...